| CPC A61F 2/915 (2013.01) [A61B 17/12036 (2013.01); A61B 17/12104 (2013.01); A61B 17/12136 (2013.01); A61F 2/06 (2013.01); A61F 2/2421 (2013.01); A61F 2/848 (2013.01); A61F 2/856 (2013.01); A61F 2/954 (2013.01); A61F 2002/061 (2013.01); A61F 2002/065 (2013.01); A61F 2002/068 (2013.01); A61F 2002/825 (2013.01); A61F 2002/828 (2013.01); A61F 2002/8486 (2013.01); A61F 2002/91508 (2013.01); A61F 2002/91575 (2013.01); A61F 2230/0065 (2013.01); A61F 2250/0039 (2013.01); A61F 2250/0067 (2013.01)] | 22 Claims |

|
1. An in-vivo intravascular apparatus for reducing symptoms associated with left ventricle failure in a human adult comprising:
(a) an anchor frame configured for anchoring the apparatus to a branch pulmonary artery of a human heart;
(b) a device frame including a flow restrictor, wherein said flow restrictor is configured to increase resistance of flow flowing out from a right ventricle of the human heart; and
(c) a connecting section connecting said device frame to said anchor frame;
(d) at least one pressure sensor attached to at least one of said anchor frame, device frame and connecting section.
|